Literature DB >> 361283

Fungal spores in lung and sputum.

J Mullins, A Seaton.   

Abstract

A survey of fungal aerospora over a 2-year period was combined with an investigation of the fungi cultured from 295 samples of peripheral human lung and 2466 samples of sputum over the same period. 83% of lung and 88% of sputum samples contained culturable fungi, although in 16% of lung and 31% of sputum samples Candida albicans was the only one. Those fungi of small spore size tended to be found in lung tissue while those with larger spores were more likely to be found in the sputum. While their presence in the respiratory tract was related to their occurrence in the air, differences in their frequencies in the air and lung suggested that the lung had a selective inhibitory effect on the development of different spores. In particular, Aspergillus fumigatus was cultured more frequently than would have been anticipated from its profusion in the air.

Entities:  

Mesh:

Year:  1978        PMID: 361283     DOI: 10.1111/j.1365-2222.1978.tb01506.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  23 in total

1.  Invasive pulmonary aspergillosis in non-immunocompromised patients.

Authors: 
Journal:  BMJ       Date:  1991-04-13

2.  Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung.

Authors:  I M Bromley; K Donaldson
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

3.  Clinical and immunological reactions to Aspergillus niger among workers at a biotechnology plant.

Authors:  M D Topping; D A Scarisbrick; C M Luczynska; E C Clarke; A Seaton
Journal:  Br J Ind Med       Date:  1985-05

4.  Clinical reactions to Aspergillus niger in a biotechnology plant: an eight year follow up.

Authors:  A Seaton; D Wales
Journal:  Occup Environ Med       Date:  1994-01       Impact factor: 4.402

5.  Suppression of host defences by Aspergillus fumigatus.

Authors:  M D Robertson; A Seaton; L J Milne; J A Raeburn
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

6.  Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.

Authors:  R Amitani; G Taylor; E N Elezis; C Llewellyn-Jones; J Mitchell; F Kuze; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Detection of Aspergillus fumigatus PCR products by a microtitre plate based DNA hybridisation assay.

Authors:  H A Fletcher; R C Barton; P E Verweij; E G Evans
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

8.  Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin.

Authors:  Elena Appel; Alexandra Vallon-Eberhard; Aharon Rabinkov; Ori Brenner; Irina Shin; Keren Sasson; Yona Shadkchan; Nir Osherov; Steffen Jung; David Mirelman
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

9.  Allergic bronchopulmonary stemphyliosis.

Authors:  S R Benatar; B Allan; R P Hewitson; P A Don
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

10.  Normally saprobic cryptococci isolated from Cryptococcus neoformans infections.

Authors:  S Krajden; R C Summerbell; J Kane; I F Salkin; M E Kemna; M G Rinaldi; M Fuksa; E Spratt; C Rodriguez; C Rodrigues
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.